Skip to main content

What Labcorp's Quarter ended Sep 30, 2026 10-Q says: 2 signals

Labcorp filed its latest 10-Q with the SEC on Oct 30, 2026. It discusses restructuring charge and software implementation.

Public (LH)Medical and Diagnostic Laboratories10,000+ employeeslabcorp.comLinkedIn

Get Labcorp's live signals in Claude or ChatGPT, or by API

AskWhat changed at Labcorp this week? Use Autobound signals for labcorp.com.
Filed
Oct 30, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
6

Source: Autobound Signal API · 75 signals tracked for Labcorp · updated

10-Q · latest 6

What Labcorp's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 2 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 30, 2026

    Filed · 2 signals

    SEC EDGAR
  3. 10-Q · Quarter ended Mar 31, 2026

    Filed · 2 signals

    SEC EDGAR
    • Debt refinancingNeutral

      Labcorp Secures $750.0M Term Loan Maturing in March 2028

      On March 20, 2026, Labcorp entered into a $750.0 million term loan maturing March 20, 2028, to repay maturing debt and fund corporate uses.

      $750M

      2026 Term Loan principal balance

    • Restructuring chargeNegative

      Labcorp Records $6.4M Net Restructuring Charges in Q1 2026

      Labcorp recorded net restructuring charges of $6.4 million in the three months ended March 31, 2026, including $14.6 million in severance and personnel costs and $1.6 million in facility-related costs.

      $6.4M

      net restructuring and other charges

Earnings calls

Labcorp earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Raised 2026 revenue guidance midpoint by $65M to 6.3%The company increased its full-year 2026 enterprise revenue growth guidance to 5.9%–6.7% (a 50 bps increase at the midpoint) and raised adjusted EPS guidance to $18.30–$18.70. This increase reflects stronger underlying organic performance in central lab and diagnostics businesses.
Acquired MLM Medical Labs and signed 3 tuck-in dealsDuring Q3, $256 million was deployed on acquisitions, including closing MLM Medical Labs to expand central lab footprint across four continents. Subsequent agreements were signed to acquire select assets of BioReference ($260M expected first-year revenue), Myriad Genetics' prenatal business ($100M revenue), and Millennium Health.
Q3 revenue grew 6.9% to $3.8B, AOI margin 15%Third quarter revenue reached $3.8 billion, representing 6.9% year-over-year reported growth (5.5% organic). Adjusted operating income margin expanded 60 basis points to 15.0%, and adjusted EPS grew 14.5% to $4.78, demonstrating operational leverage.
Biopharma segment revenue up 8.5% with $8.9B backlogBiopharma Laboratory Services (BLS) revenue reached $867 million, up 8.5% YoY (9.6% organic constant currency), driven by Central Lab Services growth of 11.3%. BLS backlog closed at $8.9 billion, with approximately $2.8 billion expected to convert to revenue over the next 12 months.
Launched FDA cleared pTau217 test for Alzheimer's diseaseThe company expanded its neurology specialty testing by launching an FDA-cleared pTau217 blood biomarker test for Alzheimer's disease in primary and specialty care settings. It also rolled out a Hepatitis D reflex test and received FDA approval for a companion diagnostic in advanced melanoma using the PGDX platform.
Building state of the art lab in IndianapolisCapital expenditures are planned at nearly 4% of total revenue as the company constructs a state-of-the-art central laboratory facility in Indianapolis to support accelerating biopharma demand. The multi-year capital commitment is incorporated into ongoing annual capex budgets.

Signal API · MCP

Track Labcorp with the Signal API

One POST /v1/companies/enrich call with labcorp.com returns Labcorp 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"labcorp.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Labcorp 10-Q

When did Labcorp file its latest 10-Q?
Labcorp filed its latest 10-Q (Quarter ended Sep 30, 2026) on Oct 30, 2026. The one before it was filed on Aug 5, 2026.
What did Labcorp disclose in its latest 10-Q?
From the filing dated Oct 30, 2026: Labcorp continues enterprise-wide ERP system implementation and integration across broader business areas
What did Labcorp say on its recent earnings calls?
Q3 FY2026: Raised 2026 revenue guidance midpoint by $65M to 6.3% (dated Oct 28, 2026).
Where can I read Labcorp's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/920148/000092014826000222/lh-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →